Therapy News and Research

RSS

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Cancer immunotherapy using "designer" immune cells has revolutionized cancer treatment in recent years. In this type of therapy, T cells, a type of white blood cell, are collected from a patient's blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) that is designed to enable T cells to recognize and destroy cancer cells.

14 Dec 2020

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.

14 Dec 2020

Expansion of telepsychiatry may outlast the COVID-19 pandemic

Once the COVID-19 pandemic is over, a lot of things will go back to normal. We'll stop wearing masks. We'll crowd into restaurants. We'll walk whatever direction we want to down grocery store aisles. But some changes that the pandemic spurred might be here to stay. Among them: the expansion of telepsychiatry.

11 Dec 2020

Researchers develop first biohybrid artificial retina with silk fibroin and retinal cells

An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.

11 Dec 2020

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND).

11 Dec 2020

Study uncovers genetic risks of Takayasu arteritis

In a paper published today in the American Journal of Human Genetics, a group of international collaborators led by researchers from the University of Pittsburgh School of Medicine identified new genetic associations that can predict individual susceptibility to a rare inflammatory disease called Takayasu arteritis.

11 Dec 2020

New AI tool could make breast cancer treatment less expensive and more readily available

Imagine being a doctor and having a precocious resident permanently by your side, giving you brilliant insight into disease and helping you to identify the best treatment path for your patients.

11 Dec 2020

Financial toxicity correlated with worse psychological well-being among breast cancer surgical patients

Financial toxicity among breast cancer patients is independently associated with worse psychological well-being following a mastectomy or lumpectomy operation.

11 Dec 2020

High expression of VRK1 protein can reduce survival in neuroblastoma patients

Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein VRK1 is associated with tumour aggressiveness and low survival among neuroblastoma patients.

11 Dec 2020

New analysis method could pave the way for important breakthroughs in immunotherapy

In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.

11 Dec 2020

Favipiravir does not attenuate the progression of COVID-19

Scientists have conducted an observational study to evaluate the efficacy of an anti-influenza medicine favipiravir in treating hospitalized COVID-19 patients.

11 Dec 2020

Study highlights shared risk of diabetes in dogs and pet owners

Owners of a dog with diabetes are more likely to develop type 2 diabetes than owners of a dog without diabetes.

11 Dec 2020

First patient participates in immunotherapy trial despite COVID-19 pandemic

Since 2016, Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but nothing has successfully eradicated the disease.

11 Dec 2020

Teenagers with severe obesity and type 2 diabetes can benefit from bariatric surgery

Cardiovascular disease is the leading cause of death in patients with type 2 diabetes, and youth with severe obesity and type 2 diabetes face a high risk of developing cardiovascular disease during their lifetime.

11 Dec 2020

Scientist pinpoints genes that promote the growth of prostate cancer cells

Research by a University of Georgia scientist sheds light on how two genes factor into prostate cancer cells becoming resistant to treatment, providing a potential new target for therapeutics.

11 Dec 2020

Researchers use AI platform to identify best combination of available therapies against COVID-19.

A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.

11 Dec 2020

Osteoporosis drug also promotes infiltration of immune cells in breast tumors

The team of Eva González-Suarez, from the CNIO and IDIBELL, and the team of Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumors.

10 Dec 2020

Melatonin and its metabolites promote the formation of long-term memories

Researchers at Tokyo Medical and Dental University in Japan show that melatonin and its metabolites promote the formation of long-term memories in mice and protect against cognitive decline.

10 Dec 2020

Testing memory over four weeks could help identify the earliest signs of Alzheimer's disease

New research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease before it has developed.

10 Dec 2020

Combination therapy places no greater burden on early-stage breast cancer patients

Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients' ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women's Cancer Center investigators shows.

10 Dec 2020

Therapy News and Research

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Expansion of telepsychiatry may outlast the COVID-19 pandemic

Researchers develop first biohybrid artificial retina with silk fibroin and retinal cells

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

Study uncovers genetic risks of Takayasu arteritis

New AI tool could make breast cancer treatment less expensive and more readily available

Financial toxicity correlated with worse psychological well-being among breast cancer surgical patients

High expression of VRK1 protein can reduce survival in neuroblastoma patients

New analysis method could pave the way for important breakthroughs in immunotherapy

Favipiravir does not attenuate the progression of COVID-19

Study highlights shared risk of diabetes in dogs and pet owners

First patient participates in immunotherapy trial despite COVID-19 pandemic

Teenagers with severe obesity and type 2 diabetes can benefit from bariatric surgery

Scientist pinpoints genes that promote the growth of prostate cancer cells

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Osteoporosis drug also promotes infiltration of immune cells in breast tumors

Melatonin and its metabolites promote the formation of long-term memories

Testing memory over four weeks could help identify the earliest signs of Alzheimer's disease

Combination therapy places no greater burden on early-stage breast cancer patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News